Moreover, the expression patterns of members of the miR-34a/ENO3 pathway in the liver tissues of NAFLD patients was in line with the findings of both cellular and animal studies. The gene discussed is ENO3; the disease is metabolic dysfunction-associated steatotic liver disease.